Biotricity Inc. (Biotricity) today announced its financial results and provided a business update for its third quarter of fiscal 2023 ended December 31, 2022.  Commenting, Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, “With our suite of state-of-the-art remote cardiac solutions now well established, Biotricity is focused on sales, marketing and achieving positive cash flow.”